SAFE-N-Medtech (safety testing in the life cycle of nanotechnology-enabled medical technologies for health) is an innovative, EU-funded, open-access platform to offer capabilities, know-how, networks, and services for the development, testing, assessment, upscaling, and market exploitation of nanotechnology-based Medical Devices.
NEUROSTECH was selected this year by SAFE-N-Medtech to participate in the open-access platform, which will help us across the whole development process of our medical device for the intrathecal release of drugs.
As a result of the selection, we have attended the 42nd month management committee of SAFE-N-Medtech as a new test case company in Barcelona, 18th-20th October 2022.
